Chronic Pain

The Gut-Joint Axisby Dr. Aoife Earls, MSc, ND345 Lakeshore Rd E Suite 212Oakville, ON L6J 1J5

Chronic pain is a significant health issue, and it is estimated that one-half of those suffering with chronic pain have been suffering for longer than 10 years.[1] An estimated 54.4 million North Americans have been diagnosed with various arthritic disorders,[2] conditions that are typically treated with nonsteroidal anti-inflammatory drugs (NSAIDs). These drugs work by inhibiting proinflammatory molecules called cytokines like interleukin-6 (IL-6), tumor necrosis factor-alpha (TNFα),

and prostaglandins.[3] It is widely known that prolonged usage of NSAIDs like Advil and Tylenol over the long term create side effects such as ulcers, gastrointestinal (GI) bleeding, heartburn, bloating, and gas.[4] NSAIDs are also known to contribute to hyperpermeability of the GI tract, or leaky gut syndrome.[5] This can lead to the development of allergies, small bacterial overgrowth syndrome, and irritable bowel syndrome, among other digestive diseases.

Alternative health professionals are often asked to support various chronic pain conditions like osteoarthritis (OA) and rheumatoid arthritis (RA), often without access to medications for pain control but more often to heal the body from the damage of using these medications. Given the prevalence of joint inflammation in irritable bowel diseases (IBD),[6][7] and the general prevalence of chronic pain and GI imbalances in aging, it is imperative that our understanding of the gut-joint axis becomes a crucial part of our management of disease, as opposed to pain elimination alone.[5][6]

Microbiome Status in Chronic Joint PainThe GI tract is widely understood to be our first line of defence against foreign invaders, through a combination of beneficial commensal bacteria and strong epithelial integrity.[8] The proper ratio of “good” flora creates balanced immunity; the presence of higher

amounts of lactic-acid bacteria, such as Lactobacilli and Bifidobacteria, positively influence T-helper regulatory cells which control immune reactivity in IBS, chronic pain, and reactive arthritis.[9][10][11] In contrast, GI tracts with higher colonies of possible pathogens, such as Clostridia or Klebsiella, may contribute to joint disease.[12][13][14] Outside of the GI tract, cross-reactivity reactions can form between host tissue bacterial antigens, leading to the production of autoantibodies and triggering inflammatory cascades within the synovium.[12]

Consumption of probiotics containing lactic-acid bacteria such as S.  thermophilus, L. bulgaricus, L.  acidophilus, or Bifidobacterium bifidus haS been associated with reduction of reactive arthritis in animal models of arthritis,[12][15][16] and both probiotics and prebiotics (inula, flax) have been shown to impact musculoskeletal disorders in human patients.[12]

However, not all “good” bacteria guarantee healthy joints. Bacterial overgrowth of the small intestine can promote the development of joint pain and systemic fibromyalgia-like syndromes. In animal models of RA, rats who were kept in sterile conditions did not develop the disease until they were exposed to normal bacterial colonies and their colons were able to grow “normal” bacterial flora.[15][17] Only after this did they develop synovitis, or joint inflammation. Germ-free rats have also been shown to have reduced gut and joint inflammation.[18] Therefore, the key is keeping bacterial flora in the right ratios, properly balanced between cellular-mediated immunity (Th1) and humoral immunity (Th2).[19] Two key strategies address this line of thought: proper nutrition and stress-hormone regulation.

Nutritional Support for ArthritisVegetarian-type diets that are rich in fibre, antioxidants like seabuckthorn and elderberry, and beneficial bacteria through fermented foods like sauerkraut and pickling for Lactobacillus, might reduce pain, thereby improving quality of life in RA patients.[23][24] With respect to OA, similar results can be seen with consumption of avocado and soy vegetable extracts, with patients seeing increased joint mobility and movement, and prevention and inhibition of joint-cartilage degradation.[25] Further research is needed to determine mechanisms and specific dietary ratios that are optimal for pain reduction.

Food Sensitivities and Joint InflammationNo specific foods have been clearly identified to eat to alleviate chronic pain, but rather foods to avoid. Sugar, for example, has been linked with increased risk for the development of RA.[20] It is also known that simple carbohydrates influence gut microbiota: In both humans and animal models, a Western diet (high fat  / high sugar) has been shown to enhance counts of disease-contributing

species (Firmicutes) and decrease counts of beneficial bacterial (Bacterioidetes) species.[21][22]

Undiagnosed food allergies and/or intolerances can be inflammatory triggers for chronic pain in the musculoskeletal system. Because food intolerances and allergies can be challenging to diagnose, and testing for these disorders is variable in terms of sensitivity and specificity (especially for intolerances of the IgG classes),[26] elimination diets are still the current gold-standard for diagnosis. Clinically speaking, reduced cow’s dairy is promising, and the most commonly explored triggers include cow’s milk antigens (α-lactalbumin, β-lactoglobulin, casein), wheat and wheat gluten, eggs (ovalbumin), and soy proteins. A case study in 1981 revealed dairy elimination reduced pain, stiffness, and grip strength in a patient with RA,[27] and a randomized controlled trial of 94 RA patients showed that elimination of milk protein in a subset of patients with dairy allergy improved their disease activity.[28]

Blood-serum testing for these sensitivities is a challenge. A group exploring food intolerances in patients with the autoimmune skin condition Sjögren’s disease investigated increased reactivity in the anal area (rectum) in response to consumption of cow’s milk protein in 8 of the 21 patients.[30] Many of these patients also had IBS symptoms, and a few were also sensitive to gluten.

Influence of Stress Hormones on the Gut-Joint AxisChronic pain itself is a physically and emotionally taxing condition. Managing stress hormones should be a significant component of treatment, especially considering the fact that chronic pain decreases quality of life, not only through changed activity levels and physical restrictions, but also by the depression and anxiety that can often develop in tandem.[31]

We know from research that the stress hormone cortisol can compromise the health of the intestine.[32] Serotonin decreases in stress, while cortisol increases.[33] Being that over 90% of serotonin is produced in the gut, when people are craving carbohydrates to increase serotonin, they may be indirectly creating more inflammation due to weight gain or the types of foods they choose to reduce this craving. Overweight OA patients have been found to have higher levels of pain compared to normal-weight individuals, and also to experience symptom relief from eating high-fat  / high-sugar foods.[31][34] Reduced amounts of the stress hormone cortisol is also a problem. Chinese medicine describes this as kidney yang deficiency (cold, aching body, exhaustion, diarrhea, IBS-like conditions), which has been shown in an animal model to be treated effectively with herbal medicine.[35]

What is fascinating is that Curcuma longa (turmeric) and its extract curcumin, well-known for its ability to improve chronic pain in most musculoskeletal conditions,[36][37][38] may also decrease stress hormone. In animal models of chronic constrictive pain, as often seen in neuropathic pain disorders in humans, hypersensitivity to pain (hyperalgesia) and cortisol levels were reduced with curcumin consumption.[39] Downregulation of IL-6, TNFα, and IL-1β, key mediators in inflammatory pain and immune chronic upregulation, are seen with curcumin interventions in similar animal models.[40] Curcumin is also able to influence Western diet–induced inflammation.[41]

Herbal Medicine and the Gut-Joint AxisBoswellia serrata, also known as Indian frankincense, is a wonderful pain-relieving herb for joint inflammation, but is also intensely healing for GI disease and OA.[42][43] It has also been shown to heal the lining of the gastrointestinal tract against previous damage and to protect against further damage in IBD.[44] It is relatively inexpensive, and there are good ethical sources of this resin available commercially. Rehmannia glutinosa, utilized for many centuries in Chinese medicine as a cortisol regulator, adaptogen (stress-modulator), and mediator in autoimmunity, has been shown in rat models to reduce chronic neuropathic pain in a dose-dependent manner.[43]

ConclusionThat many individuals are seeking out nutritional or herbal treatments to support or reduce dependence on pharmaceutical pain intervention for chronic pain is encouraging. We are forced, again, to look at the root causes of pain expression, rather than to merely palliate, despite our ability to do so and our personal desire to alleviate suffering. By continuing to focus on the gut-joint axis, we are led to more successful management of chronic pain.

References1. Institute of Medicine (US) Committee on Advancing Pain Research, Care, and Education. Relieving pain in America: A blueprint for transforming

prevention, care, education, and research. Washington, DC, The National Academies Press, 2011, 382 p., ISBN 978‑0309256278.

2. Centers for Disease Control and Prevention. Arthritis-Related Statistics. · http://www.cdc.gov/arthritis/data_statistics/arthritis_related_stats.htm · Updated 2015‑03‑17. · Accessed 2019‑02‑18.

3. Gallelli, L., et al. “The effects of nonsteroidal anti‑inflammatory drugs on clinical outcomes, synovial fluid cytokine concentration and signal transduction pathways in knee osteoarthritis. A randomized open label trial.” Osteoarthritis and cartilage, Vol. 21, No. 9 (2013): 1400–1408.

4. Scarpignato, C., and R. H. Hunt. “Nonsteroidal antiinflammatory drug‑related injury to the gastrointestinal tract: Clinical picture, pathogenesis, and prevention.” Gastroenterology clinics of North America, Vol. 39, No. 3 (2010): 433–464.

5. Tachecí, I., et al. “Non‑steroidal anti‑inflammatory drug induced injury to the small intestine.” Acta Medica (Hradec Kralove), Vol. 53, No. 1 (2010): 3–11.

6. Sheth, T., C.S. Pitchumoni, and K.M. Das. “Musculoskeletal manifestations in inflammatory bowel disease: A revisit in search of immunopathophysiological mechanisms.” Journal of clinical gastroenterology, Vol. 48, No. 4 (2014): 308–317.

7. Brakenhoff, L.K., et al. “The joint‑gut axis in inflammatory bowel diseases.” Journal of Crohn’s & colitis, Vol. 4, No. 3 (2010): 257–268.

8. Keita, A.V., and J.D. Soderholm. “The intestinal barrier and its regulation by neuroimmune factors.” Neurogastroenterology and motility, Vol. 22, No. 7 (2010): 718–733.

9. Theodorou, V., et al. “Effect of commensals and probiotics on visceral sensitivity and pain in irritable bowel syndrome.” Gut microbes, Vol. 5, No. 3 (2014): 430–436.

10. Gul’neva, M.Iu., and S.M. Noskov. “[Colonic microbial biocenosis in rheumatoid arthritis.]” [Article in Russian] Klinicheskaia meditsina, Vol. 89, No. 4 (2011): 45–48.

11. Reichenberger, E.R., et al. “Establishing a relationship between bacteria in the human gut and complex regional pain syndromes.” Brain, behavior, and immunity, Vol. 29 (2013): 62–69.

12. Vitetta, L., et al. “The gastrointestinal microbiome and musculoskeletal diseases: A beneficial role for probiotics and prebiotics.” Pathogens, Vol. 2, No. 4 (2013): 606–626.

13. Rashid, T., C. Wilson, and A. Ebringer. “The link between ankylosing spondylitis, Crohn’s disease, Klebsiella, and starch consumption.” Clinical & developmental immunology, Vol. 2013 (2013): 872632.

14. Kohn, D. “Joint pain, from the gut.” The Atlantic. · http://www.theatlantic.com/health/archive/2015/01/joint‑pain‑from‑the‑gut/383772/ · Posted 2015‑01‑12. · Accessed 2015‑05‑02.

15. Noto Llana, M., et al. “Consumption of Lactobacillus casei fermented milk prevents Salmonella reactive arthritis by modulating IL‑23/IL‑17 expression.” PLoS one, Vol. 8, No. 12 (2013): e82588.

16. Baharav, E., et al. “Lactobacillus GG bacteria ameloriate arthritis in Lewis rats.” The Journal of nutrition, Vol. 134, No. 8 (2004): 1964–1969.

17. Toivanen, P. “Normal intestinal microbiota in the aetiopathogenesis of rheumatoid arthritis.” Annals of the rheumatic diseases, Vol. 62, No. 9 (2003): 807–811.

18. Taurog, J.D., et al. “The germfree state prevents development of gut and joint inflammatory disease in HLA–B27 transgenic rats.” The Journal of experimental medicine, Vol. 180, No. 6 (1994): 2359–2364.

19. Liévin‑Le Moal, V., and A.L. Servin. “The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: Mucins, antimicrobial peptides, and microbiota.” Clinical microbiology reviews, Vol. 19, No. 2 (2006): 315–337.

20. Hu, Y., et al. “Sugar‑sweetened soda consumption and risk of developing rheumatoid arthritis in women.” The American journal of clinical nutrition, Vol. 100, No. 3 (2014): 959–967.

21. Turnbaugh, P. J., et al. “The effect of diet on the human gut microbiome: A metagenomic analysis in humanized gnotobiotic mice.” Science translational medicine, Vol. 1, No. 6 (2009): 6ra14.

22. Thomas, F., et al. “Environmental and gut bacteroidetes: The food connection.” Frontiers in microbiology, Vol. 2 (2011): 93.

23. Hagen, K.B., et al. “Dietary interventions for rheumatoid arthritis.” The Cochrane database of systematic reviews, Vol. 1 (2009): CD006400.

24. Nenonen, M.T., et al. “Uncooked, Lactobacilli‑rich, vegan food and rheumatoid arthritis.” British journal of rheumatology, Vol. 37, No. 3 (1998): 274–281.

25. Christiansen, B.A., et al. “Management of osteoarthritis with avocado/soybean unsaponifiables.” Cartilage, Vol. 6, No. 1 (2015): 30–44.

26. Lessoff, M.B., et al. “Food allergy and intolerance in 100 patients‑local and systemic effects.” The Quarterly journal of medicine, Vol. 49, No. 195 (1980): 259–271.

27. Parke, A.L., and G.R. Hughes. “Rhematoid arthritis and food: A case study.” British medical journal (Clinical research ed.), Vol. 282, No. 6281 (1981): 2027–2029.

28. van de Laar, M.A., and J.K. van der Korst. “Food intolerance in rheumatoid arthritis. I. A double blind, controlled trial of the clinical effects of elimination of milk allergens and azo dyes.” Annals of the rheumatic diseases, Vol. 51, No. 3 (1992): 298–302.

29. Hvatum, M., et al. “The gut–joint axis: Cross reactive food antibodies in rheumatoid arthritis.” Gut, Vol. 55, No. 9 (2006): 1240–1247.

30. Lidén, M., et al. “Cow’s milk protein sensitivity assessed by the mucosal patch technique is related to irritable bowel syndrome in patients with primary Sjögren’s syndrome.” Clinical and experimental allergy, Vol. 38, No. 6 (2008): 929–935.

31. Generaal, E., et al. “Reduced hypothalamic‑pituitary‑adrenal axis activity in chronic multi‑site musculoskeletal pain: ̈ Partly masked by depressive and anxiety disorders.” BMC musculoskeletal disorders, Vol. 15 (2014): 227.

32. Hayes, P.A., M.H. Fraher, and E.M. Quigley. “Irritable bowel syndrome: The role of food in pathogenesis and management.” Gastroenterology & hepatology, Vol. 10, No. 3 (2014): 164–174.

33. Markus, C.R. “Effects of carbohydrates on brain tryptophan availability and stress performance.” Biological psychology, Vol. 76, No. 1–2 (2007): 83–90.

34. Choi, K.W., et al. “The relationship between pain and eating among overweight and obese individuals with osteoarthritis: An ecological momentary study.” Pain research & management, Vol. 19, No. 6 (2014): e159–e163.

35. Zhao, L., et al. “Metabolic signatures of kidney yang deficiency syndrome and protective effects of two herbal extracts in rats using GC/TOF MS.” Evidence-based complementary and alternative medicine, Vol. 2013 (2013): 540957.

36. Jurenka, J.S. “Anti‑inflammatory properties of curcumin, a major constituent of Curcuma longa: A review of preclinical and clinical research.” Alternative medicine review, Vol. 14, No. 2 (2009): 141–153.

37. Belcaro, G., et al. “Meriva®+glucosamine versus condroitin+glucosamine in patients with knee osteoarthritis: An observational study.” European review for medical and pharmacological sciences, Vol. 18, No. 24 (2014): 3959–3963.

38. Nakagawa, Y., et al. “Short‑term effects of highly‑bioavailable curcumin for treating knee osteoarthritis: A randomized, double‑blind, placebo‑controlled prospective study.” Journal of orthopaedic science, Vol. 19, No. 6 (2014): 933–939.

39. Di, Y.X., et al. “Curcumin attenuates mechanical and thermal hyperalgesia in chronic constrictive injury model of neuropathic pain.” Pain and therapy, Vol. 3, No. 1 (2014): 59–69.

40. Singh, A.K., and M. Vinayak. “Curcumin attenuates CFA induced thermal hyperalgesia by modulation of antioxidant enzymes and down regulation of TNF‑α, IL‑1β and IL‑6.” Neurochemical research, Vol. 40, No. 3 (2015): 463–472.

41. Ghosh, S.S., et al. “Oral supplementation with non‑absorbable antibiotics or curcumin attenuates western diet‑induced atherosclerosis and glucose intolerance in LDLR–/– mice – role of intestinal permeability and macrophage activation.” PLoS one. Vol. 9, No. 9 (2014): e108577.

42. Cameron, M., and S. Chrubasik. “Oral herbal therapies for treating osteoarthritis.” The Cochrane database of systematic reviews, Vol. 5 (2014): CD002947.

43. Bolognesi, G., et al. “Movardol® (N‑acetylglucosamine, Boswellia serrata, ginger) supplementation in the management of knee osteoarthritis: Preliminary results from a 6‑month registry study.” European review for medical and pharmacological sciences, Vol. 20, No. 24) (2016): 5198–5204.

44. Catanzaro, D., et al. “Boswellia serrata preserves intestinal epithelial barrier from oxidative and inflammatory damage.” PLoS one, Vol. 10, No. 5 (2015): e0125375.

45. Wang, Y., et al. “Analgesic activity of catalpol in rodent models of neuropathic pain, and its spinal mechanism.” Cell biochemistry and biophysics, Vol. 70, No. 3 (2014): 1565–1571.